The approved therapy Edaravone, used for amyotrophic lateral sclerosis (ALS) and stroke, may be a promising treatment for neuromyelitis…
Articles by Lindsey Shapiro, PhD
Reaching a neuromyelitis optica spectrum disorder (NMOSD) diagnosis in the absence of disease-causing antibodies requires careful attention from physicians…
Older age, diagnostic delays, and a greater disability at diagnosis were associated with a higher risk of developing permanent disability…
Age, sex, and spinal lesions may be risk factors for developing pain due to nerve damage — called neuropathic pain…
Women with neuromyelitis optica spectrum disorder (NMOSD) who received immunosuppressive treatment during pregnancy or were at least 32 years…
Key players in B-cell signaling pathways and related inflammatory molecules were elevated in the blood of people with neuromyelitis…
Rituximab worked better than other treatments at preventing relapses in people with neuromyelitis optica spectrum disorder (NMOSD) who have…
The video series “Imagine My Life With NMO” has been launched by the Sumaira Foundation to help others in…
Enspryng (satralizumab) and tocilizumab — two interleukin-6 (IL-6) receptor inhibitors that prevent inflammation — are generally…
Asymptomatic, or “silent,” MRI lesions are not common during disease remission in patients with aquaporin-4 antibody neuromyelitis…